Xcell Therapeutics (XKRX:373110) Other Net Income (Loss) : ₩0 Mil (TTM As of Sep. 2024)

View and export this data going back to 2024. Start your Free Trial

What is Xcell Therapeutics Other Net Income (Loss)?

Xcell Therapeutics's Other Net Income (Loss) for the three months ended in Sep. 2024 was ₩0 Mil. Its Other Net Income (Loss) for the trailing twelve months (TTM) ended in Sep. 2024 was ₩0 Mil.

Xcell Therapeutics Other Net Income (Loss) Historical Data

The historical data trend for Xcell Therapeutics's Other Net Income (Loss) can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Xcell Therapeutics Other Net Income (Loss) Chart

Xcell Therapeutics Annual Data

Trend

Dec19

Dec20

Dec21

Dec22

Dec23

Other Net Income (Loss)

Xcell Therapeutics Quarterly Data
	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24
Other Net Income (Loss)	Get a 7-Day Free Trial			-	-	-	-	-

Xcell Therapeutics Other Net Income (Loss) Calculation

Different companies can and do choose to report each of income statement items separately. Yet, there are a variety of items which are simply too numerous to list. Therefore GuruFocus uses a standardized financial statement format for all companies. Other Net Income (Loss) may include but is not limited to items such as net income (loss) from discontinuing operations, extraordinary, earnings from equity interest net of tax, etc. After-tax income and Other Net Income (Loss) together constitute Net Income Including Noncontrolling Interests.

Other Net Income (Loss) for the trailing twelve months (TTM) ended in Sep. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was ₩0 Mil.

Xcell Therapeutics Other Net Income (Loss) Related Terms

Thank you for viewing the detailed overview of Xcell Therapeutics's Other Net Income (Loss) provided by GuruFocus.com. Please click on the following links to see related term pages.

Xcell Therapeutics Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Xcell Therapeutics Inc (XKRX:373110) » Definitions » Other Net Income (Loss)

Comparable Companies

Traded in Other Exchanges

N/A

Address

333, Yeongdong-daero, Gangnam-gu, Seoul, KOR, 06188

Website

http://www.xcell.media

Xcell Therapeutics Inc operates as a research company engaged in development of regenerative medicines. The company is developing proliferation media for various animal cell types.

Xcell Therapeutics Headlines

No Headlines